Literature DB >> 28490788

Low-dose IL-2 therapy - a complex scenario that remains to be further explored.

Jens Y Humrich1, Gabriela Riemekasten1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28490788     DOI： 10.1038/nrrheum.2017.71

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  6 in total

1.  The rise of IL-2 therapy - a picture beyond Treg cells.

Authors:  Zhanguo Li; Jing He; Di Yu
Journal:  Nat Rev Rheumatol       Date:  2017-05-11       Impact factor: 20.543

2.  Clinical trials: The rise of IL-2 therapy - a novel biologic treatment for SLE.

Authors:  Jens Y Humrich; Gabriela Riemekasten
Journal:  Nat Rev Rheumatol       Date:  2016-10-20       Impact factor: 20.543

3.  Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus.

Authors:  Caroline von Spee-Mayer; Elise Siegert; Dimas Abdirama; Angelika Rose; Anika Klaus; Tobias Alexander; Philipp Enghard; Birgit Sawitzki; Falk Hiepe; Andreas Radbruch; Gerd-Rüdiger Burmester; Gabriela Riemekasten; Jens Y Humrich
Journal:  Ann Rheum Dis       Date:  2015-08-31       Impact factor: 19.103

4.  Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.

Authors:  Jing He; Xia Zhang; Yunbo Wei; Xiaolin Sun; Yaping Chen; Jun Deng; Yuebo Jin; Yuzhou Gan; Xin Hu; Rulin Jia; Chuanhui Xu; Zhaohua Hou; Yew Ann Leong; Lei Zhu; Jinhong Feng; Yuan An; Yuan Jia; Chun Li; Xu Liu; Hua Ye; Limin Ren; Ru Li; Haihong Yao; Yuhui Li; Shi Chen; Xuewu Zhang; Yin Su; Jianping Guo; Nan Shen; Eric F Morand; Di Yu; Zhanguo Li
Journal:  Nat Med       Date:  2016-08-08       Impact factor: 53.440

5.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.

Authors:  Nabila Seddiki; Brigitte Santner-Nanan; Jeff Martinson; John Zaunders; Sarah Sasson; Alan Landay; Michael Solomon; Warwick Selby; Stephen I Alexander; Ralph Nanan; Anthony Kelleher; Barbara Fazekas de St Groth
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

6.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307
  6 in total
  5 in total

Review 1.  Rebalancing Immune Homeostasis to Treat Autoimmune Diseases.

Authors:  David A Horwitz; Tarek M Fahmy; Ciriaco A Piccirillo; Antonio La Cava
Journal:  Trends Immunol       Date:  2019-10-07       Impact factor: 16.687

2.  Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.

Authors:  Florian Weigold; Jeannine Günther; Moritz Pfeiffenberger; Otavio Cabral-Marques; Elise Siegert; Duska Dragun; Aurélie Philippe; Ann-Katrin Regensburger; Andreas Recke; Xinhua Yu; Frank Petersen; Rusan Catar; Robert Biesen; Falk Hiepe; Gerd R Burmester; Harald Heidecke; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2018-03-22       Impact factor: 5.156

3.  IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis.

Authors:  Angelika Rose; Caroline von Spee-Mayer; Lutz Kloke; Kaiyin Wu; Anja Kühl; Philipp Enghard; Gerd-Rüdiger Burmester; Gabriela Riemekasten; Jens Y Humrich
Journal:  Cells       Date:  2019-10-11       Impact factor: 6.600

Review 4.  What Makes Antibodies Against G Protein-Coupled Receptors so Special? A Novel Concept to Understand Chronic Diseases.

Authors:  Gabriela Riemekasten; Frank Petersen; Harald Heidecke
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

5.  IL-2-Agonist-Induced IFN-γ Exacerbates Systemic Anaphylaxis in Food Allergen-Sensitized Mice.

Authors:  Christopher W M Link; Christina N Rau; Christopher C Udoye; Mohab Ragab; Rabia Ü Korkmaz; Sara Comdühr; Ann-Katrin Clauder; Timo Lindemann; Britta Frehse; Katharina Hofmann; Larissa N Almeida; Yves Laumonnier; Asmaa El Beidaq; Fred D Finkelman; Rudolf A Manz
Journal:  Front Immunol       Date:  2020-12-11       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.